A hormone secreted by fat cells can restrain the growth of liver cancer in mice, report researchers.

New findings "suggest that a relatively inexpensive therapy, vitamin B12 and folic acid, could be used to prevent and/or delay the progression of NASH."

As studies signal serious health consequences, specialists scramble to treat acute cases and reinforce limits that define moderate use.

A combination immunotherapy significantly slowed liver cancer growth and enhanced the strength of tumor-attacking T cells in mice, researchers say.

A noninvasive sound technology can destroy between 50 and 75% of tumors in rat livers, with the immune system handling what's left.

Exercise has a multitude of benefits for people with nonalcoholic fatty liver disease, including a reduced risk of developing blood clots.

A discovery in mice about the role imprinted genes play in the development of non-alcoholic fatty liver disease could lead to new treatments.

A one-year increase in alcohol consumption in the U.S. during the COVID-19 pandemic is estimated to cause 8,000 additional deaths from alcohol-related liver disease by 2040.

The same dose of a drug can have varying degrees of effectiveness and safety depending on how well the liver can metabolize it.

"...consumption of both sucrose- and high fructose corn-sweetened beverages increase liver fat and decrease insulin sensitivity..."